| Name | Title | Contact Details |
|---|
BSI was founded by Judith C. McDowall in 1985 to prepare documentation for FDA regulatory submissions. BSI began preparing peer reviewed technical reports for the National Toxicology Program in 1989. We obtained and have retained this prestigious
Sarepta Therapeutics, headquartered in Cambridge, Massachusetts, is a commercial-stage biopharmaceutical company focused on the discovery and development of precision genetic medicine to treat rare diseases. Sarepta is at the forefront of precision genetic medicine, having built an impressive and competitive position in Duchenne muscular dystrophy (DMD) and more recently in Limb-girdle muscular dystrophy (LGMD), Charcot-Marie-Tooth (CMT) and CNS-related disorders, reaching a total of over 20 therapies in various stages of development. The Company`s programs span across several therapeutic modalities, including RNA, gene therapy and gene editing. Sarepta is poised to be the most meaningful precision genetic medicine company in the world and make a profound difference in the lives of patients suffering from rare neuromuscular diseases and other rare diseases.
Statline is a Greenwood Vlg, CO-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
Fluresh is a premium vertically integrated medical & adult use cannabis company obsessed with quality and wellness. We believe that each individual connection between a patient and cannabis is unique, dynamic and matchless.
At Shannondale, we believe our residents` senior years should be stress-free and wonderful, so we offer a full continuum of care from short-term rehab to independent living to assisted or skilled nursing. We offer two locations in Knoxville and Maryville. Our community at Shannondale is strengthened by nurturing, compassionate, experienced staff who have innate passion for caring for others. We pride ourselves in a welcoming environment not only for residents, but for staff as well, with competitive benefits.